SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN)
CAPS Rating:
A biopharmaceutical company, which is engaged in the development and commercialization of novel therapeutics to treat life-threatening diseases.
A biopharmaceutical company, which is engaged in the development and commercialization of novel therapeutics to treat life-threatening diseases.
Recs
No debt, huge cashflow. One of the few US based companies with market penetration in China.